Shopping Cart 0
Cart Subtotal
USD 0

Stentys SA (STNT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Stentys SA (Stentys) is a medical device company that designs, develops and markets self-expanding stents for the treatment of patients with acute myocardial infarction and coronary disease. The company's products include BMS and DES stents, self apposing coronary stent systems, SES stents; self-apposing bare metal stents and drug eluting stent, and aspiration catheter stents, among others. Its self apposing drug-eluting stents are designed to adapt to vessels with ambiguous or fluctuating diameters to prevent the malapposition problems associated with conventional stents. Stentys conducts clinical program to demonstrate the safety and efficacy of its products. The company has operations in Germany, France, Italy, the Netherlands, Scandinavia, Poland, Spain and Switzerland. Stentys is headquartered in Paris, France.

Stentys SA (STNT)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Stentys SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Stentys SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Stentys SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Stentys SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Stentys SA, Medical Devices Deals, 2012 to YTD 2018 9

Stentys SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Stentys SA, Pharmaceuticals & Healthcare, Deal Details 11

Equity Offering 11

Stentys Raises USD14.6 Million in Rights Offering of Shares 11

Stentys Completes Rights Issue Of Shares For USUSD47.3 Million 12

Acquisition 13

Stentys Acquire Minvasys for USD9.2 Million 13

Stentys SA-Key Competitors 14

Stentys SA-Key Employees 15

Stentys SA-Locations And Subsidiaries 16

Head Office 16

Other Locations & Subsidiaries 16

Recent Developments 17

Financial Announcements 17

Apr 12, 2018: STENTYS: Financial Information for the First Quarter of 2018 17

Jan 08, 2018: STENTYS Reports Revenues for the Fourth Quarter and Full Year 2017 18

Oct 12, 2017: STENTYS: Revenues for the Third Quarter of 2017: Continued Growth for the Xposition S Stent 19

Oct 02, 2017: STENTYS: 2017 half-year results 20

Jul 12, 2017: STENTYS: Revenues Of EUR1.7 Million in the Second Quarter Of 2017 21

Apr 24, 2017: STENTYS Reports a 22% Increase in Revenues in the First Quarter of 2017 22

Jan 12, 2017: STENTYS: 2016 Annual Revenues up 20% at EUR7.3 Million 23

Corporate Communications 24

Apr 03, 2017: STENTYS is Strengthening Its Board by Co-Opting Two New Independent Members 24

Appendix 25

Methodology 25

About GlobalData 25

Contact Us 25

Disclaimer 25


List Of Figure

List of Figures

Stentys SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Stentys SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Stentys SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Stentys SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Stentys SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Stentys SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Stentys SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Stentys SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Stentys SA, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Stentys SA, Pharmaceuticals & Healthcare, Key Facts, 2016 2

Stentys SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Stentys SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Stentys SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Stentys SA, Deals By Therapy Area, 2012 to YTD 2018 8

Stentys SA, Medical Devices Deals, 2012 to YTD 2018 9

Stentys SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Stentys Raises USD14.6 Million in Rights Offering of Shares 11

Stentys Completes Rights Issue Of Shares For USUSD47.3 Million 12

Stentys Acquire Minvasys for USD9.2 Million 13

Stentys SA, Key Competitors 14

Stentys SA, Key Employees 15

Stentys SA, Subsidiaries 16

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Stentys SA, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.